Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 September 2021 | Story Leonie Bolleurs | Photo Supplied
Prince Matova, a PhD student in the Department of Plant Sciences, has been working on breeding a maize that can resist the fall armyworm (FAW) – a maize-eating pest. Later in September, he will receive the Young Scientist Award from the Plant Mutation Breeding Division of the International Atomic Energy Agency (IAEA) and the Food and Agriculture Organisation of the United Nations (FAO).

Prince Matova, a PhD student in Plant Breeding at the University of the Free State (UFS), received the Young Scientist Award from the Joint Food and Agriculture Organisation of the United Nations (FAO)/International Atomic Energy Agency (IAEA) Division of Nuclear Techniques in Food and Agriculture for excellence in plant mutation breeding.

The IAEA Director-General, Mr Rafael Mariano Grossi, will officially announce the award at the 65th regular session of the IAEA General Conference that will take place later in September this year.

The award is given to scientists younger than 40, who have made a significant contribution and impact in the field of mutation breeding.

Matova, a researcher, research and agronomy manager, and maize and legumes breeder at Mukushi Seeds (Pvt) Ltd in Harare, Zimbabwe, says: “People have seen the little work that I have done, and they were happy with it. That makes me happy too.”

Other contributions

In the ten years collaborating with the IAEA, practising mutation breeding, Matova – who believes innovative thinking and self-motivation to be contributing factors to a successful scientist – has also been recognised for other outstanding contributions. These include the release of a cowpea mutant variety in 2017 and its wide dissemination across Zimbabwe, as well as the modernisation of the maize and cowpea national breeding programmes. He has also contributed two publications and appeared twice at IAEA Plant Mutation Breeding symposia. Furthermore, Matova has trained other scientists and fellows across Africa and collaborated with centres of excellence in plant breeding, research, and development.

Growing up, he never guessed that he would one day become an agricultural scientist. Matova was, however, very good at biology and believes that this is one of the reasons why he ended up in crop science. “I am enjoying every moment of it. I love innovativeness and inventions and I view hybrid maize variety development as the greatest innovation in plant breeding. Working for Mukushi Seeds is inspiring; I have a young and dedicated team and the environment allows me to explore my full potential.”

“I feel science solves problems and every day as I do my breeding work, I have this desire to achieve greatness by developing a super maize hybrid,” he says.

Displaying excellence

For the past three to four years, Matova has been working to breed maize varieties that can resist fall armyworm (FAW) – a maize-eating pest. He says the pest has caused significant maize crop yield and economic losses across Africa.

More than 300 million smallholder farmers across sub-Saharan Africa rely on maize for food and livelihoods. “These farmers have limited capacities to control the pest. They are using insecticides, which we have seen to effectively provide immediate control of the pest.” However, these pesticides have environmental and health issues. “It is against this background that we, as plant breeders, felt it was important to develop varieties that are resistant to the pest. It is a more environmentally friendly, less expensive, and more sustainable solution,” explains Matova.
In his research, he evaluated the breeding potential of exotic FAW-resistant donor lines with local lines. He also investigated the resistance response and stability of local cultivars and inbred lines against FAW. 

While working at the Zimbabwean Department of Research and Specialist Services (DR&SS), Matova collaborated with the International Maize and Wheat Improvement Center (CIMMYT), the University of Zimbabwe, the UFS, and the IAEA to look into the possibility of using mutation breeding in maize crop improvement, with the intention to enhance FAW-resistance in maize genotypes.

He introgressed FAW resistance into the elite breeding materials at both DR&SS and Mukushi Seeds, where he is currently working. Matova believes that although FAW resistance is currently a nice-to-have trait, going forward, all maize varieties released should have a baseline resistance to FAW.

Ultimately, his work generated important information that can guide research and maize breeding for FAW resistance in Southern Africa. All this information is free for researchers to use for the betterment of Africa and the world.

Inspired by greatness

There are a number of people in the industry and academia who have inspired Matova. The list includes Dr Cosmos Magorokosho (CIMMYT), Prof Hussein Shimelis (University of KwaZulu-Natal), Dr Fatma Sarsu (IAEA), Dr Marilyn Warburton (Agricultural Research Service in the United States Department of Agriculture), Dr Amsal Terekegne (ZAMSEED), and Dr John MacRobert (Mukushi Seeds). They all contributed in one way or another to influence Matova in a positive way towards becoming the passionate scientist he is today.

Besides this list of prominent names, Matova says that he was more recently also motivated and encouraged by his PhD supervisor and mentor, Prof Maryke Labuschagne, Professor in Plant Sciences at the UFS. “She is a very special person doing a wonderful job. Prof Labuschagne is kind, thorough, hardworking, and a good mentor,” he states.

Prof Labuschagne is very proud of Matova for receiving this award. “He has been working really hard, and this is a wonderful recognition of the time and effort that he has invested in his research,” she says.


News Archive

HIV Cure – Just another fantasy?
2016-07-27

Description: HIV Cure – Just another fantasy? Tags: HIV Cure – Just another fantasy?

Dr Dominique Goedhals, Prof John Frater,
Dr Thabiso Mofokeng and Dr Jacob Jansen van Vuuren,
attended the lecture. Prof Frater has been working in
collaboration with the UFS Department of Internal
Medicine on HIV resistance and HIV immunology
since 2007.

Photo: Nonsindiso Qwabe

Twenty-years ago, after a person had been diagnosed with HIV, their lifespan did not exceed three years, but thanks to the success of antiretroviral therapy programmes, life expectancy has risen by an average of ten years. However, is antiretroviral therapy always going to be for life? This is the societal issue that Professor John Frater, addressed in his talk at the University of the Free State. He is an MRC Senior Clinical Fellow, Associate Professor and Honorary Consultant Physician in Infectious Diseases at  Oxford University.

Antiretroviral medicine therapeutic

The discovery of antiretroviral therapy - the use of HIV medicines to treat the virus - has had a positive effect on the health and well-being of people living with it, improving their quality of life. Unfortunately, if treatment is stopped, HIV rebounds to the detriment of the patient. Now, research has shown that some patients, who are treated soon after being infected by HIV, may go off treatment for prolonged periods. Work is being done to predict who will be able to stop treatment.

“The difference made by starting treatment earlier is enormous. Delaying treatment is denying yourself the right to health,” Professor Frater says. However, this does not mean that the virus is cured. “A person can live for ten years without being on HIV treatment, but is that enough?” he went on to ask.

Healthy lifestyles encouraged

The National Department of Health will adopt a test and treat immediately strategy later this year to improve patient health and curb the spread of HIV. ,This is another reason why everybody should know their status and start treatment as soon as possible.

Search for a cure continues

More research is being conducted to establish whether HIV can be eradicated. Remission gives hope that a permanent cure may be found eventually. “Will a cure for HIV ever be found? Time will tell,” he concluded.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept